Sharon Stack Two papers involving ovarian cancer research at the University of Notre Dame’s Harper Cancer Research Institute (HCRI), one featuring new research and the other a review article, were published as cover stories in their respective journals.

Professor Reginald Hill New Notre Dame research has been used to support the Orphan Drug designation for IT-139, a compound that when used in combination with chemotherapy has proved to be significantly more effective in treating pancreatic cancer than the current standard of care.

The newly launched IDEA Center plans to turn the innovations of 15 Notre Dame student and faculty researchers into viable commercial entities in the coming yea r— and to advance the common good in the process.      

The University of Notre Dame will lead an $11.5 million project funded by the National Institutes of Health (NIH) to better understand the genes responsible for drug resistance and virulence in the malaria parasite in order to reduce and ultimately eliminate the deadly disease.

The Indiana Clinical and Translational Sciences Institute (CTSI) has opened its grant competition for the Fall Pilot Funding for Research Use of Core Facilities. This pilot funding program was created to bring awareness to the state-of-the-art technology and specific expertise available

The University of Notre Dame’s Advanced Diagnostics & Therapeutics (AD&T) initiative announced the recipients of its 2017 Discovery Fund awards, which provide seed funding to some of the most creative ideas being developed by Notre Dame faculty and their collaborators in areas of biomedical, environmental, and behavioral health.

The Mike and Josie Harper Cancer Research Institute at the University of Notre Dame will host a community breast cancer seminar Sept. 13 (Wednesday) at Raclin-Carmichael Hall, 1234 N. Notre Dame Ave., as part of its occasional Community Seminar Series. Doors open at 5 p.m., followed by presentations and a...

Join Siuyan Zhang, the Nancy Dee Assistant Professor of Cancer Research and Assistant Professor of Biological Sciences at the University of Notre Dame, on Tuesday, October 10, 2017 at 4:00pm in 283 Galvin for a seminar titled Unraveling Bewildered Tumor Ecosystem – From Molecular Insights to Clinical Translation.

Notre Dame Research invites faculty, staff, post-doctoral scholars, graduate and undergraduate students, as well as external customers to attend the Core Facility Fair on Wednesday, September 20, 2017. From 12:00 to 4:00 p.m. in the McCourtney Hall B01 Auditorium, attendees will be able to learn how state-of-the-art instrumentation and expertise...

Research extends from the most common cause of heart attacks to a rare brain disorder affecting children   The University of Notre Dame’s Advanced Diagnostics & Therapeutics (AD&T) initiative announced the recipients of its 2017 Discovery Fund awards, which provide seed funding to some of the most creative ideas being...

Researchers at the Harper Cancer Research Institute, which is a collaboration between the University of Notre Dame and the Indiana University School of Medicine South Bend (IUSM-SB), are working with community partners to not only foster awareness of ovarian cancer, but to develop tests for early detection, create novel chemotherapies,...

The University of Notre Dame’s Edwin Michael, Professor, Department of Biological Sciences and member of the Eck Institute for Global Health, and his team of researchers have developed a model to assess the utility of using dyethalcarbamazine (DEC) treated salt. Their research was recently published in Nature’s Scientific Reports, a...